A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...

Discover the subtle warning signs of metastatic cancer that are often overlooked. Learn how early detection of cancer spread ...

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

Brain metastases are common in people with non-small cell lung cancer. Here’s how they’re treated and diagnosed. Lung cancer is one of the cancers most likely to spread to the brain.

“Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Emrelis was approved for a type of non-squamous non-small cell lung cancer (NSCLC), for which patients were previously treated with other drugs but the disease still spread to other parts of the body.

In patients with nonirradiated brain metastases at baseline (n = 30), the confirmed CNS ORR by BICR per CNS RECIST was 33.3% (95% CI, 17.3 to 52.8). The safety profile (National Cancer Institute ...

Amplia Therapeutics is making strides with its candidate that works on the anti-fibrotic path to tackling pancreatic cancer.

THE College of Science of the University of the Philippines Diliman on May 26 said that its biologists have developed a ...